U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414550) titled 'Radiotherapy for Refractory Hidradenitis Suppurativa' on Jan. 22.
Brief Summary: The goal of this clinical trial is to learn if high-dose radiotherapy can provide sustained disease relief in moderate to severe, treatment resistant Hidradenitis suppurativa patients; could include any of the following: any sex/gender, and those greater then 18 years old. The main question[s] it aims to answer are:
Outcome measure 1: Will radiotherapy change the number of inflammatory nodules, abscesses, and draining sinus tracts in the treated axilla compared with the untreated axilla? Outcome measure 2: Will radiotherapy positively change a patient'...